Using macrophages overexpressing TREM2, we demonstrated that the transfer of a single dose of these macrophages in UIRI mice successfully reduced renal inflammation, glomerular damage and tubulointerstitial fibrosis, which are the hallmarks of CKD. This evidence concerns the gene TREM2 and chronic kidney disease.